Edition:
United States

Search Results  for '600521.SS'

Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Zhejiang Huahai Pharmaceutical Co Ltd: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

24 Sep 2016 Reuters Investment Profile 12 $20.00

Thomson Reuters Stock Report - Zhejiang Huahai Pharmaceutical Co Ltd (600521-SH)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

25 Sep 2016 Thomson Reuters Stock Report 11 $25.00

Wright Investors Service Comprehensive Report for Zhejiang Huahai Pharmaceutical

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

24 Sep 2016 Wright Reports 65 $75.00

Is There Long-Term Value in Zhejiang Huahai Pharmaceutical Co., Ltd.?

22 Sep 2016 Sadif Analytics Prime 12 $25.00

Zhejiang Huahai Pharmaceutical Co., Ltd. (600521) - Financial and Strategic SWOT Analysis Review

Zhejiang Huahai Pharmaceutical Co., Ltd. (600521) - Financial and Strategic SWOT Analysis Review Summary Zhejiang Huahai Phar...

19 Sep 2016 GlobalData 51 $300.00

Zhejiang Huahai Pharmaceutical Co., Ltd.: Downgraded to Average

19 Jul 2016 Sadif Analytics Prime 3 $10.00

Will Zhejiang Huahai Pharmaceutical Co., Ltd. Deliver Long-Term Returns?

23 Jun 2016 Sadif Analytics Prime 12 $25.00

Zhejiang Huahai Pharmaceutical Co., Ltd. (600521) - Financial and Strategic SWOT Analysis Review

Zhejiang Huahai Pharmaceutical Co., Ltd. (600521) - Financial and Strategic SWOT Analysis Review Summary Zhejiang Huahai Phar...

09 Jun 2016 GlobalData 51 $300.00

Zhejiang Huahai Pharmaceutical Co., Ltd.: Upgraded to Above Average

16 May 2016 Sadif Analytics Prime 3 $10.00

Thomson Reuters Stock Report - Zhejiang Huahai Pharmaceutical Co Ltd (600521-SH)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

10 May 2016 Thomson Reuters Stock Report 11 $25.00